Gilead settles with US government in long-running patent dust-up over PrEP meds Truvada, Descovy

After a run of court victories in a five-year patent dispute with the U.S. government, Gilead Sciences has agreed to settle with the Department of Justice (DOJ) and the Department of Health and Human Services (HHS) to resolve the feds’ last-ditch appeal.